Research output per year
Research output per year
Research output
- 34 results
Search results
-
2024
Empowering choices: a journey into influencing factors for patients and surgeons in designing patient decision aids for hip and knee osteoarthritis
Ahlmann Pedersen, T., Jensen, C. M., Lindberg-Larsen, M., Varnum, C. & Dahl Steffensen, K., 9. Jul 2024, In: BMJ Evidence-Based Medicine. 29, Suppl. 1, p. A91 195.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Informed decisions: unveiling the process of developing and field-testing a decision aid for hip or knee osteoarthritis
Ahlmann Pedersen, T., Jensen, C. M., Lindberg-Larsen, M., Varnum, C. & Dahl Steffensen, K., 9. Jul 2024, In: BMJ Evidence-Based Medicine. 29, Suppl. 1, p. A1-A2 003.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Language as a barrier to culturally sensitive and safe cancer care: An interview study with patients and family caregivers
Birkelund, L., Dieperink, K. B., Sodemann, M., Falby Lindell, J., Dahl Steffensen, K. & Nielsen, D. S., 29. Jun 2024, (Accepted/In press) In: Journal of Transcultural Nursing.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Psychometric evaluation of the Danish version of the hip and knee decision quality instrument (HK-DQI)
Ahlmann Pedersen, T., Dahl Steffensen, K., Sepucha, K., Lindberg-Larsen, M., Jensen, C. M., Ingwersen, K. G., Bræmer, C. N. & Varnum, C., 9. Jul 2024, In: BMJ Evidence-Based Medicine. 29, Suppl. 1, p. A91-A92 196.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
2023
Putting Patients from Ethnic Minority Backgrounds and their Families First: Two Qualitative Studies on the Impact of Language
Birkelund, L., Dieperink, K. B., Sodemann, M., Lindell, J., Dahl Steffensen, K. & Nielsen, D. S., 2023, In: Journal of Family Nursing.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
2022
Healthcare encounters with older patients with cancer and limited dominant language proficiency
Birkelund, L., Dieperink, K. B., Sodemann, M., Lindell, J., Dahl Steffensen, K. & Nielsen, D. S., 19. Jul 2022, In: European Geriatric Medicine. 13, Suppl. 1, p. 327 1 p., P-726.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Practitioners’ views on shared decision-making implementation: A qualitative study
Ankolekar, A., Dahl Steffensen, K., Olling, K., Dekker, A., Wee, L., Roumen, C., Hasannejadasl, H. & Fijten, R., May 2022, In: Radiotherapy & Oncology. 170, Supplement 1, p. 883-884 PO-1048.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
The Multilingual Encounter in the Danish Healthcare System: an upcoming PhD study
Birkelund, L., Dieperink, K. B., Sodemann, M., Lindell, J., Dahl Steffensen, K. & Nielsen, D. S., 2022, In: International Journal of Integrated Care. 22, Suppl. 3, 2 p., 61.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open AccessFile50 Downloads (Pure) -
2021
A multi-institution analysis of relapsed lymphoma occurring during pregnancy, including pharmacokinetics with antenatal checkpoint inhibitor therapy
Farooq, F., Cardonick, E. H., Polushkina, E., Ahmed, S., Ramakrishnan, P., J. Olszewski, A., Yasin, H., Hamad, N., Lin, Y., Edmonds, J., Ciavolino, L., Maggen, C., Fruschio, R., Gziri, M. M., Dahl Steffensen, K., Farooq, U., Amant, F., Elad, S., Yin, T. & Figg, W. D. & 4 others, , Dec 2021, In: Blood. 138, 2457, p. 2457 1 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Characterization of patients with BRCA mutated ovarian cancer who are eligible versus not eligible for PARP inhibitor maintenance therapy: exploratory analysis of the VELIA study
Swisher, E., Kaufmann, S., Okamoto, A., Steffensen, K., Bookman, M., Moore, K., Sullivan, D., Bach, B., Ratajczak, C., Chen, B., Dinh, M., Ansell, P. & Coleman, R., 1. Aug 2021, In: Gynecologic Oncology. 162, Suppl. 1, p. S106-S107Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
2020
Health-related quality of life (HRQoL) in patients (pts) with newly diagnosed stage III or IV ovarian cancer treated with veliparib (vel) + chemotherapy followed by vel maintenance (maint)
Cella, D., Bookman, M. A., Dahl Steffensen, K., Coleman, R. L., Dinh, M. H., Khandelwal, N., Benjamin, K., Kamalakar, R., Sullivan, D. M., Floden, L. & Hudgens, S., 2020, In: Annals of Oncology. 31, (suppl_4)Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Health-related quality of life (HRQoL) in patients (pts) with newly diagnosed stage III or IV ovarian cancer treated with veliparib (vel) plus chemotherapy followed by vel maintenance (maint)
Cella, D., Bookman, M., Steffensen, K. D., Coleman, R. L., Dinh, M., Khandelwal, N., Benjamin, K., Kamalakar, R., Sullivan, D., Floden, L. & Hudgens, S., 1. Sept 2020, In: Annals of Oncology. 31, Suppl. 4, p. S612 1 p., 809MO.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
National coverage of biological materials for translational research in the Danish cancerbiobank (RBGB) and of corresponding clinical data in the Danish Gynecological Cancer Database (DGCD)
Hogdall, E., Schnack, T., Steffensen, K. D., Jochumsen, K., Kahr, H. S., Ingerslev, K., Antonsen, S. L., Christensen, I. J. & Hogdall, C., 1. Oct 2020, In: Gynecologic Oncology. 159, Suppl. 1, p. 299-300 2 p., 645.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
PFS by blinded independent central review (BICR) in the VELIA trial of veliparib (V) plus carboplatin/paclitaxel (CP) and as monotherapy in newly diagnosed patients (pts) with high-grade serous ovarian cancer (HGSC)
Aghajanian, C., Bookman, M. A., Fleming, G. F., Brady, M. F., Swisher, E. M., Dahl Steffensen, K., Friedlander, M., Okamoto, A., Moore, K. N., Sullivan, D. M., Fallstrøm, M., Dinh, M. H., Ratajczak, C. K. & Coleman, R. L., 2020, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 15 Suppl., 6077.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial
Swisher, E. M., Coleman, R. L., Bookman, M. A., Brady, M. F., Fleming, G. F., Friedlander, M., Cunningham, M. J., Tewari, K. S., Edraki, B., Moxley, K., Mantia-Smaldone, G. M., Ratajczak, C., Dinh, M. H., Sullivan, D. M., McClain, S., Okubo, S., Steffensen, K. D. & Aghajanian, C., 1. Oct 2020, In: Gynecologic Oncology. 159, Suppl. 1, p. 20-21 2 p., 37.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study
Okamoto, A., Fleming, G. F., Bookman, M. A., Brady, M. F., Swisher, E. M., Dahl Steffensen, K., Cloven, N. G., Enomoto, T., Dinh, M. H., Coleman, R. L. & Aghajanian, C., 17. Sept 2020, In: Annals of Oncology. 31, Suppl. 4, p. S618 1 p., 818P.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
2019
Correlation between natural killer cell activity and treatment effect in patients with disseminated cancer
Hansen, T. F., Nederby, L., Zedan, A. H., Mejlholm, I., Henriksen, J. R., Dahl Steffensen, K., Thomsen, C. B., Raunkilde, L., Jensen, L. H. & Jakobsen, A., 1. Jun 2019, In: Journal of Clinical Oncology. 36, 15 Supplement, 12029.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
HOXA9 methylation in circulating tumor DNA as a prognostic biomarker in patients with platinum-resistant ovarian cancer
Faaborg , L., Henriksen, J. R., Fredslund Andersen, R., Adimi, P., Jakobsen, A. & Dahl Steffensen, K., 12. Sept 2019, In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 29, Suppl. 3, p. A139 1 p., 335.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Natural killer cells and treatment effect in recurrent ovarian cancer
Henriksen, J. R., Nederby, L., Donskov, F., Jakobsen, A., Adimi, P., Waldstrøm, M. & Dahl Steffensen, K., 20. Sept 2019, In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 29, Suppl. 3, p. A33 1 p., 59.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Prognostic impact of tumor infiltrating natural killer cells in ovarian carcinoma
Henriksen, J. R., Donskov, F., Waldstrøm, M., Braad Petersen, C., Jakobsen, A. & Dahl Steffensen, K., 19. Sept 2019, In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 29, Suppl. 3, p. A3 1 p., 4.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Tissue immune response in epithelial ovarian carcinoma
Henriksen, J., Donskov, F., Waldstrom, M., Hjortkjaer, M., Petersen, C. B., Thomsen, C. B., Jakobsen, A. K. M. & Steffensen, K. D., 20. May 2019, In: Journal of Clinical Oncology. 37, 15 Supplement, p. 2625-2625 2625.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)
Coleman, R. L., Fleming, G. F., Brady, M. F., Swisher, E., Steffensen, K. D., Friedlander, M., Okamoto, A., Moore, K., Ben-Baruch, N., Werner, T. L., Oaknin, A., Nam, J.-H., Leath III, C. A., Nicum, S., Cella, D., Sullivan, D. M., Ansell, P. J., Dinh, M., Aghajanian, C. & Bookman, M. A., Oct 2019, In: Annals of Oncology. 30, Suppl. 5, p. 895-896 2 p., LBA3.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
VELIA/GOG-3005: Integration of veliparib with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin
Coleman, R. L., Fleming, G. F., Brady, M. F., Swisher, E. M., Dahl Steffensen, K., Friedlander, M., Okamoto, A., Moore, K. N., Efrat Ben-Baruch, N., Werner, T. L., Oaknin, A., Nam, J.-H., Leath, C. A., Nicum, S., Cella, D., Sullivan, D. M., Ansell, P. J., Dinh, M. H., Aghajanian, C. & Bookman, M. A., 28. Sept 2019, In: Annals of Oncology. 30, Suppl. 5, p. v851-v934Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
2018
HOXA9 methylation in circulating tumor DNA as a prognostic biomarker in BRCA-mutated ovarian cancer patients treated with PARP inhibitor
Rusan, M., Fredslund Andersen, R., Jakobsen, A. & Dahl Steffensen, K., 20. Oct 2018, In: Annals of Oncology. 29, Suppl. 8, p. viii341 1 p., 954P.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
2017
Can postponement of death be used in shared decision making in patients treated with adjuvant chemotherapy?
Trabjerg, N. D., Hansen, T. F., Dahl Steffensen, K., Jakobsen, A. & Jensen, L. H., 8. Sept 2017, In: Annals of Oncology. 28, Suppl. 5, p. 561-562 1598P.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Monitoring the effect of cytostatic treatment by immune activity
Hansen, T. F., Bechmann, T., Jacobsen, E. H., Zedan, A., Mejlholm, I., Henriksen, J. R., Dahl Steffensen, K., Brenner Thomsen, C. E., Raunkilde Larsen, L., Jensen, L. H. & Jakobsen, A., 8. Sept 2017, In: Annals of Oncology. 28, Suppl. 5, p. 578 1 p., 1644P.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Oncological Management and Pregnancy Outcomes in Women Diagnosed With Cancer During Pregnancy: A 20-Year International Cohort Study of 1170 Patients
Verheecke, M., Van Calsteren, K., Fruscio, R., Lok, C. A., Zola, P., Ottevanger, P. B., Peccatori, F. A., Dahl Steffensen, K., Han, S. N. & Amant, F., 6. Nov 2017, In: International Journal of Gynecological Cancer. 27, Suppl. 4Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Postponement of death weighed against duration of treatment and toxicity as key components in shared decision making about last line oncologic treatment.
Jensen, L. H., Trabjerg, N. D., Hansen, T. F., Jakobsen, A. & Dahl Steffensen, K., Jun 2017, In: Journal of Clinical Oncology. 35, Suppl. 15, p. 1 e21555.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
2014
Matched cohort study on patients with cervical cancer diagnosed during pregnancy
Amant, F., Uzan, C., Han, S. N., Fruscio, R., Dahl Steffensen, K., Škultéty, J., Giuliani, D., Mephon, A., Rouzier, R., Witteveen, P., Locatelli, A., Rob, L. & Halaska, M. J., 2014, In: Annals of Oncology. 25, 4 (Supplement), p. iv320 1 p., 925P.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Sentinel lymph node biopsy for breast cancer treatment during pregnancy: On behalf of the International Network of Cancer, Infertility and Pregnancy (INCIP) and the German Breast Group (GBG)
Han, S. N., Amant, F., Sangalli, C., Loibl, S., Gheysens, O., Lok, C. A. R., Dahl Steffensen, K., Halaska, M. J., Peccatori, F. A. & Gentilini, O., 2014, In: Annals of Oncology. 25, 4 (Supplement), 1 p., 266PD_PR.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Unplanned pregnancy during cancer treatment - on behalf of the International Network of Cancer, Infertility and Pregnancy (INCIP)
van Peer, S., Han, S. N., Dahl Steffensen, K., Halaska, M. J., Gziri, M. M., van Calsteren, K. & Amant, F., 2014, In: Annals of Oncology. 25, 4 (Supplement), 1527P_PR.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
2011
Improved classification of epithelial ovarian cancer into type 1 and type 2 tumors: Results of three Danish cohorts
Dahl Steffensen, K., Waldstrøm, M., Grove, A., Lund, B., Pallisgaard, N. & Jakobsen, A., Sept 2011, In: International Journal of Gynecological Cancer. 21, Suppl 3Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
2010
Panitumumab and pegylated liposomal doxorubicin to platinum-resistant epithelial ovarian cancer with KRAS wild-type: An ongoing, nonrandomized, multicenter, phase II trial
Dahl Steffensen, K., Waldstrøm, M., Lund, B., Bergfeldt, K., Keldsen, N., Marth, C., Vergote, I. & Jakobsen, A., 2010, In: Journal of Clinical Oncology. 28:15s, 2010 (suppl; abstr TPS254), suppl, p. TPS254Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
2007
COX2 expression and relation to long-term survival in epithelial ovarian cancer
Dahl Steffensen, K., Waldstrøm, M., Jeppesen, U., Brandslund, I. & Jakobsen, A., 2007, In: APMIS. 115, 3, p. 277Research output: Contribution to journal › Conference abstract in journal › Research › peer-review